Trials / Completed
CompletedNCT06282263
The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses
The Effect of the Awareness Development Program on Suicide Prevention for Oncology Nurses on the Levels of Suicide Knowledge, Stigma and Perception of Efficacy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Sevda Ozturk · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to investigate the effect of the Awareness Development Programme on Suicide Prevention for Oncology Nurses on the levels of knowledge, stigma and perception of efficacy towards suicide in oncology nurses. The main questions it aims to answer are: 1. At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the knowledge levels of nurses about suicide according to the pre-programme and control group? 2. At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the perception of efficacy levels of nurses regarding suicide according to the pre-programme and control group. 3. At the end of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology and at the end of the 3-month follow-up, is there a difference between the stigma levels of nurses towards suicide according to the pre-programme and control group. 4. Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test and post-test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology. 5. Is there a significant relationship between the levels of knowledge about suicide, perception of efficacy regarding suicide, and stigma towards suicide in the pre-test-follow-up test measurements of the Awareness Development Programme on Suicide Prevention for Oncology Nurses applied to nurses working in the field of oncology. Participants will participate the Awareness Development Programme on Suicide Prevention for Oncology Nurses. Oncology Nurses are expected to complete the pre-test, post-test and follow-up tests. Researchers will compare control group to see if effect of "the Awareness Development Programme on Suicide Prevention"
Detailed description
This research is an intervention study with a pre-test, post-test, follow-up design and control group, which was conducted to examine the effect of the "Awareness Development Program on Suicide Prevention for Oncology Nurses" on oncology nurses' knowledge, stigma and effectiveness perception levels regarding managing suicide risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | "Awareness Development Program on Suicide Prevention for Oncology Nurses" | While developing the "Awareness Development Programme on Suicide Prevention for Oncology Nurses" applied to the nurses in the experimental group, literature information on suicide risk management and suicide prevention in oncology was included in the study content by the researchers. "Awareness Development Programme on Suicide Prevention for Oncology Nurses" includes 3 sessions and the titles of the programme are as follows: Session 1: Introduction to Understanding Suicide "Awareness and Development" Session 2: Assessing Suicide Risk Session 3: Management of Suicide Risk "Communication and Referral" The programme was submitted to the opinions of 5 experts before starting the study and the programme was finalised after the feedbacks. |
Timeline
- Start date
- 2023-05-25
- Primary completion
- 2023-11-02
- Completion
- 2023-11-02
- First posted
- 2024-02-28
- Last updated
- 2024-02-28
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06282263. Inclusion in this directory is not an endorsement.